US Broker Ratings

Auna SA (AUNA) Stock Analysis: Healthcare Giant with a 34% Upside Potential

Auna SA (AUNA), a prominent player in the healthcare sector, is capturing investor interest with its impressive potential upside. As it navigates the medical care facilities..

ArriVent BioPharma (AVBP) Stock Report: Exploring a 43.82% Potential Upside in the Biotech Arena

In the dynamic world of biotechnology, ArriVent BioPharma, Inc. (NASDAQ: AVBP) stands out as a promising player, particularly for investors seeking high-growth opportunities in the healthcare..

MBX Biosciences (MBX) Stock Analysis: Strong Buy Ratings and Significant Upside Potential

MBX Biosciences, Inc. (MBX), a promising player in the biotechnology sector, is gaining notable attention from investors with its robust pipeline of innovative therapies aimed at..

Replimune Group, Inc. (REPL) Stock Analysis: A Biotech Play with a 1.09% Potential Upside

Replimune Group, Inc. (NASDAQ: REPL) has been capturing the attention of investors with its innovative approach to cancer treatment through oncolytic immunotherapies. As a clinical-stage biotechnology..

Sonida Senior Living, Inc. (SNDA) Investor Outlook: Exploring Growth Potential Amid 38.5% Revenue Surge

Sonida Senior Living, Inc. (SNDA), a key player in the healthcare sector specializing in medical care facilities, is attracting investor attention with its impressive 38.5% revenue..

Altimmune, Inc. (ALT) Stock Analysis: Uncovering a 472% Potential Upside in the Biotechnology Sector

Altimmune, Inc. (NASDAQ: ALT), a prominent player in the biotechnology sector, is capturing investor attention with its robust potential upside of 472.17%, as indicated by analyst..

Geron Corporation (GERN) Stock Analysis: Exploring a 170.70% Potential Upside in the Biotech Arena

Geron Corporation (NASDAQ: GERN) stands at a pivotal moment in its evolution as a biopharmaceutical leader, capturing the attention of investors with its promising pipeline and..

Maze Therapeutics, Inc. (MAZE): Investor Outlook on a Biotech Stock with 119% Potential Upside

Maze Therapeutics, Inc. (NASDAQ: MAZE), a clinical-stage biopharmaceutical company specializing in precision medicines for kidney and metabolic diseases, has captured the attention of investors with its..

Cross Country Healthcare, Inc. (CCRN) Stock Analysis: Navigating Challenges with Strategic Staffing Solutions

Cross Country Healthcare, Inc. (CCRN) operates within the dynamic and essential healthcare sector, specifically focusing on medical care facilities. With a market capitalization of $428.06 million,..

LifeMD, Inc. (LFMD) Stock Analysis: Unpacking the 186.76% Potential Upside

LifeMD, Inc. (NASDAQ: LFMD) presents a compelling opportunity for investors looking to tap into the burgeoning telehealth market. As a direct-to-patient telehealth company, LifeMD offers a..

Enliven Therapeutics, Inc. (ELVN) Stock Analysis: A Biotech Contender with 17.99% Upside Potential

For investors with a keen eye on the healthcare sector, Enliven Therapeutics, Inc. (NASDAQ: ELVN) presents a compelling opportunity. This clinical-stage biopharmaceutical company, with a market..

Avanos Medical, Inc. (AVNS) Stock Analysis: Exploring Growth Prospects in the Medical Devices Sector

Avanos Medical, Inc. (NYSE: AVNS) stands as a notable player in the healthcare sector, specifically within the medical devices industry. Headquartered in Alpharetta, Georgia, Avanos has..

Ginkgo Bioworks Holdings, Inc. (DNA) Stock Analysis: Navigating Challenges Amid Biotechnology Innovations

Ginkgo Bioworks Holdings, Inc. (NASDAQ: DNA) is a prominent player in the biotechnology industry, renowned for its pioneering work in cell engineering and biosecurity. As investors..

Castle Biosciences, Inc. (CSTL) Stock Analysis: Exploring a 44% Upside Potential in the Diagnostics Sector

For individual investors seeking opportunities in the healthcare sector, Castle Biosciences, Inc. (NASDAQ: CSTL) presents a compelling case. As a key player in the diagnostics and..

Talkspace, Inc. (TALK) Stock Analysis: Exploring the 18% Potential Upside in Virtual Behavioral Healthcare

Investors eyeing the burgeoning field of telehealth might find Talkspace, Inc. (NASDAQ: TALK) an intriguing prospect. With its unique position in the virtual behavioral healthcare industry,..

AbCellera Biologics Inc. (ABCL) Stock Analysis: A 60.80% Potential Upside in the Biotech Sector

AbCellera Biologics Inc. (NASDAQ: ABCL) is making waves in the biotechnology sector with its innovative approach to antibody-based medicines. As a Canadian company with a market..

InnovAge Holding Corp. (INNV)

⚠️ No article content returned.

..

Akebia Therapeutics, Inc. (AKBA) Investor Outlook: Analyzing a 340% Potential Upside Amid Healthcare Innovation

Akebia Therapeutics, Inc. (NASDAQ: AKBA) finds itself at an intriguing juncture for investors, particularly those with an eye for high-reward opportunities in the biopharmaceutical sector. With..

Tectonic Therapeutic, Inc. (TECX) Investor Outlook: Exploring a 159.58% Potential Upside

Tectonic Therapeutic, Inc. (NASDAQ: TECX), a burgeoning player in the biotechnology sector, is rapidly gaining traction among investors with a compelling proposition: a potential upside of..

Beta Bionics, Inc. (BBNX) Stock Analysis: 42% Potential Upside Amidst Innovative Diabetes Solutions

Investors with an eye on the healthcare sector, particularly within the medical devices industry, might find Beta Bionics, Inc. (NASDAQ: BBNX) an intriguing opportunity. With a..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds